Organon & Co | OGN - Pre Tax Profit


Organon & Co reported $243M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Celltrion KRW 14.6B 180.89B Jun/2025
Cspc Pharmaceutical CNY 505.59M 706M Dec/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Divis Laboratories Ltd INR 8.54B 580M Dec/2025
Gilead Sciences USD 3.64B 1.21B Sep/2025
Glaxosmithkline GBP 2.46B 569M Sep/2025
Kangmei Pharma CNY 2.07M 13.77M Sep/2025
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Laboratorios Farma EUR 26.78M 94.77M Jun/2025
Medical Developments International AUD -149K 466K Jun/2025
Merck USD 6.74B 22M Sep/2025
Neuren Pharmaceuticals AUD 9.86M 161.24M Jun/2025
Novartis USD 5.17B 637M Sep/2025
Organigram Holdings CAD -41.72M 25.52M Sep/2025
Organon & Co USD 243M 14M Sep/2025
Pharma Mar EUR 40.2M 44.28M Dec/2025
Qiagen NV USD 134.73M 7.91M Sep/2025
Sartorius EUR 85M 14.1M Sep/2025
Tilray USD -39.96M 39.19M Sep/2025
Zealand Pharma A/S -406.5M 39.77M Dec/2025